| 000 | 01858 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516031722.0 | ||
| 264 | 0 | _c20110720 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1744-8042 | ||
| 024 | 7 |
_a10.2217/pgs.10.191 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLamba, Jatinder K | |
| 245 | 0 | 0 |
_aIdentification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes. _h[electronic resource] |
| 260 |
_bPharmacogenomics _cMar 2011 |
||
| 300 |
_a327-39 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacokinetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCytarabine _xpharmacokinetics |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Networks and Pathways _xgenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCrews, Kristine R | |
| 700 | 1 | _aPounds, Stanley B | |
| 700 | 1 | _aCao, Xueyuan | |
| 700 | 1 | _aGandhi, Varsha | |
| 700 | 1 | _aPlunkett, William | |
| 700 | 1 | _aRazzouk, Bassem I | |
| 700 | 1 | _aLamba, Vishal | |
| 700 | 1 | _aBaker, Sharyn D | |
| 700 | 1 | _aRaimondi, Susana C | |
| 700 | 1 | _aCampana, Dario | |
| 700 | 1 | _aPui, Ching-Hon | |
| 700 | 1 | _aDowning, James R | |
| 700 | 1 | _aRubnitz, Jeffrey E | |
| 700 | 1 | _aRibeiro, Raul C | |
| 773 | 0 |
_tPharmacogenomics _gvol. 12 _gno. 3 _gp. 327-39 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs.10.191 _zAvailable from publisher's website |
| 999 |
_c20718603 _d20718603 |
||